NYSE:CNC - Centene Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $83.91
  • Forecasted Upside: 31.12 %
  • Number of Analysts: 17
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 13 Buy Ratings
  • 1 Strong Buy Ratings
$63.99
▼ -1.04 (-1.60%)
1 month | 3 months | 12 months
Get New Centene Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CNC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$83.91
▲ +31.12% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $83.91, with a high forecast of $103.00 and a low forecast of $67.50. The average price target represents a 31.12% upside from the last price of $63.99.
Buy
The current consensus among 17 contributing investment analysts is to buy stock in Centene. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/25/2019
  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/23/2019
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/21/2020
  • 1 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/20/2020
  • 1 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/19/2020
  • 1 strong buy ratings
  • 16 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/17/2020
  • 1 strong buy ratings
  • 17 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/16/2020
  • 1 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/15/2021

Latest Recommendations

  • 1 strong buy ratings
  • 13 buy ratings
  • 3 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/15/2021Jefferies Financial GroupDowngradeBuy ➝ Hold$75.00 ➝ $72.00Medium
i
12/21/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$83.00 ➝ $77.00Medium
i
12/14/2020SVB LeerinkLower Price TargetOutperform$80.00 ➝ $75.00High
i
Rating by D. Ha at SVB Leerink LLC
11/11/2020Piper SandlerBoost Price TargetOverweight$83.00 ➝ $89.00Medium
i
10/28/2020Credit Suisse GroupLower Price TargetNeutral$72.50 ➝ $67.50Medium
i
10/28/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$87.00 ➝ $83.00High
i
10/28/2020SVB LeerinkBoost Price TargetOutperform$78.00 ➝ $80.00High
i
Rating by D. Ha at SVB Leerink LLC
9/22/2020StephensDowngradeOverweight ➝ Equal WeightMedium
i
9/22/2020BarclaysBoost Price TargetOverweight$72.00 ➝ $84.00High
i
7/29/2020Jefferies Financial GroupLower Price TargetBuy$85.00 ➝ $83.00Low
i
7/29/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$80.00 ➝ $87.00Medium
i
7/1/2020SVB LeerinkInitiated CoverageOutperform$78.00High
i
Rating by S. Davis at SVB Leerink LLC
6/12/2020OppenheimerInitiated CoverageBuy$90.00Low
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
4/29/2020Bank of AmericaReiterated RatingBuy$82.00Low
i
Rating by Kevin Fischbeck at Bank of America Co.
4/29/2020Credit Suisse GroupReiterated RatingHold$72.50Low
i
4/29/2020CitigroupBoost Price TargetBuy$70.00 ➝ $81.00High
i
4/29/2020OppenheimerBoost Price TargetOutperform$83.00 ➝ $90.00High
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
4/29/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$82.00 ➝ $80.00High
i
4/28/2020OppenheimerReiterated RatingBuy$83.00High
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
4/13/2020Morgan StanleyBoost Price TargetOverweight$85.00 ➝ $89.00Low
i
4/13/2020SunTrust BanksBoost Price TargetBuy$85.00 ➝ $90.00High
i
3/27/2020Morgan StanleyBoost Price TargetOverweight$82.00 ➝ $85.00Low
i
3/6/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$84.00 ➝ $82.00Medium
i
2/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$68.00 ➝ $84.00High
i
2/7/2020The Goldman Sachs GroupInitiated CoverageBuy$80.00Low
i
2/5/2020CitigroupBoost Price TargetBuy$65.00 ➝ $72.00High
i
2/5/2020JPMorgan Chase & Co.Initiated CoverageNeutral ➝ Overweight$88.00High
i
2/5/2020Credit Suisse GroupBoost Price TargetNeutral$65.00 ➝ $72.50High
i
2/4/2020OppenheimerInitiated CoverageBuy$83.00High
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
2/3/2020Evercore ISIInitiated CoverageOutperform$90.00Low
i
1/28/2020Sanford C. BernsteinBoost Price TargetTop Pick$84.00 ➝ $103.00High
i
1/24/2020SunTrust BanksReiterated RatingBuy$77.00 ➝ $85.00Low
i
1/24/2020Wells Fargo & CompanyBoost Price TargetOverweight$72.00 ➝ $85.00High
i
1/8/2020Credit Suisse GroupBoost Price TargetNeutral$57.00 ➝ $65.00High
i
1/6/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$72.00High
i
12/16/2019Piper Jaffray CompaniesReiterated RatingBuy$80.00Medium
i
Rating by Sarah James at Piper Jaffray Companies
12/16/2019BMO Capital MarketsBoost Price TargetPositive ➝ Outperform$65.00 ➝ $70.00High
i
10/23/2019Deutsche Bank AktiengesellschaftLower Price TargetBuy$62.00 ➝ $60.00Low
i
10/23/2019Credit Suisse GroupLower Price TargetNeutral$63.00 ➝ $57.00High
i
9/26/2019Morgan StanleyLower Price TargetOverweight$64.00 ➝ $62.00High
i
Rating by Ricky Goldwasser at Morgan Stanley
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$62.00High
i
8/23/2019Morgan StanleyLower Price TargetOverweight$71.00 ➝ $64.00Medium
i
7/12/2019Morgan StanleyLower Price TargetOverweight$75.00 ➝ $71.00Medium
i
5/10/2019CitigroupUpgradeNeutral ➝ Buy$69.00Medium
i
4/24/2019SunTrust BanksLower Price TargetBuy$80.00Low
i
4/24/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$83.00 ➝ $75.00Low
i
4/21/2019Cantor FitzgeraldReiterated RatingBuy$83.00Low
i
3/31/2019CowenReiterated RatingBuy$77.00Low
i
3/29/2019Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$76.00 ➝ $63.00Low
i
3/29/2019ArgusDowngradeHoldLow
i
2/28/2019CowenInitiated CoverageOutperform$77.00High
i
2/27/2019Cantor FitzgeraldReiterated RatingBuy$83.00Medium
i
2/7/2019Jefferies Financial GroupReiterated RatingBuy$76.00Low
i
2/6/2019OppenheimerLower Price TargetOutperform$165.00 ➝ $83.00Low
i
1/14/2019StephensInitiated CoverageOverweight$73.50Medium
i
12/17/2018The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyHigh
i
12/17/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$72.50 ➝ $82.50High
i
12/13/2018Cantor FitzgeraldReiterated RatingBuy$72.50High
i
10/24/2018SVB LeerinkUpgradeMarket Perform ➝ Outperform$79.84High
i
Rating by A. Gupte at SVB Leerink LLC
10/2/2018OppenheimerBoost Price TargetOutperform ➝ Outperform$73.00 ➝ $79.00Low
i
9/19/2018Mitsubishi UFJ Financial GroupInitiated CoverageOverweight$85.00Low
i
Rating by J. Twizell at Mitsubishi UFJ Financial Group
9/5/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$69.00 ➝ $87.50Low
i
9/4/2018Credit Suisse GroupBoost Price TargetNeutral$67.00 ➝ $76.00Low
i
7/25/2018Piper Jaffray CompaniesReiterated RatingBuy$76.00Low
i
7/25/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$62.50 ➝ $67.00Low
i
7/25/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$68.00 ➝ $69.00Medium
i
7/25/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$67.50 ➝ $72.50Medium
i
7/24/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$72.50 ➝ $79.00Medium
i
7/23/2018BarclaysInitiated CoverageOverweight$79.00Low
i
7/18/2018CitigroupReiterated RatingNeutral$73.50Low
i
7/13/2018Morgan StanleyBoost Price TargetOverweight$63.50 ➝ $68.00Low
i
6/18/2018OppenheimerBoost Price Target$65.00 ➝ $69.00Low
i
6/18/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$56.00 ➝ $62.50Medium
i
6/18/2018BMO Capital MarketsBoost Price TargetPositive ➝ Outperform$75.00Low
i
Rating by Matthew Borsch at BMO Capital Markets
6/18/2018SVB LeerinkBoost Price TargetMarket Perform$60.00 ➝ $65.00Medium
i
6/18/2018Cantor FitzgeraldBoost Price TargetOverweight$68.50Medium
i
6/18/2018Wells Fargo & CompanyBoost Price TargetOutperform$63.00 ➝ $71.00Medium
i
4/25/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$63.00 ➝ $63.50Low
i
4/2/2018Cantor FitzgeraldReiterated RatingBuy$62.50Low
i
3/26/2018BMO Capital MarketsReiterated RatingBuyLow
i
Rating by Matthew Borsch at BMO Capital Markets
2/13/2018SVB LeerinkReiterated RatingMarket Perform ➝ Market Perform$50.00 ➝ $45.00Low
i
2/7/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$55.00 ➝ $56.00Low
i
2/7/2018Cantor FitzgeraldBoost Price TargetBuy ➝ Overweight$57.50 ➝ $62.50Low
i
2/7/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$59.00 ➝ $63.00Medium
i
2/7/2018CitigroupReiterated RatingOutperform$61.00 ➝ $65.00Low
i
1/3/2018The Goldman Sachs GroupInitiated CoverageBuy$67.50Medium
i
12/20/2017OppenheimerBoost Price TargetOutperform$55.50 ➝ $61.00Low
i
12/18/2017Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$56.00 ➝ $57.50Medium
i
12/18/2017Piper Jaffray CompaniesReiterated RatingBuy$67.00High
i
12/18/2017Cantor FitzgeraldReiterated RatingBuy$57.50High
i
12/15/2017OppenheimerReiterated RatingBuy$55.50High
i
11/8/2017OppenheimerReiterated RatingBuy$55.50N/A
i
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$51.00N/A
i
10/25/2017OppenheimerBoost Price TargetOutperform$52.50 ➝ $55.50N/A
i
10/24/2017OppenheimerReiterated RatingBuy$52.50N/A
i
10/24/2017Cantor FitzgeraldReiterated RatingBuy$53.50N/A
i
10/24/2017CowenReiterated RatingBuy$57.50N/A
i
10/17/2017BMO Capital MarketsInitiated CoverageOutperform$60.00N/A
i
10/13/2017Jefferies Financial GroupBoost Price TargetBuy$49.00 ➝ $56.00N/A
i
9/29/2017OppenheimerReiterated RatingBuy$52.50Low
i
9/21/2017Morgan StanleyBoost Price TargetOverweight$47.00 ➝ $51.50Low
i
9/14/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$47.50 ➝ $55.50Low
i
9/13/2017SVB LeerinkReiterated RatingMarket Perform ➝ Market Perform$39.00 ➝ $45.00High
i
9/13/2017CowenReiterated RatingOutperform$38.50 ➝ $52.50High
i
9/13/2017Cantor FitzgeraldBoost Price TargetOverweight$53.50High
i
9/1/2017Piper Jaffray CompaniesReiterated RatingBuy$52.50Low
i
7/27/2017Jefferies Financial GroupReiterated RatingBuy$49.00Low
i
7/27/2017Piper Jaffray CompaniesReiterated RatingBuy$52.50Medium
i
7/26/2017CitigroupBoost Price TargetSell$40.00 ➝ $44.50Medium
i
7/26/2017UBS GroupReiterated RatingBuy$44.00 ➝ $47.50Low
i
7/26/2017Morgan StanleyReiterated RatingOverweight$43.00 ➝ $47.00Low
i
7/25/2017Cantor FitzgeraldReiterated RatingBuy$45.00High
i
7/14/2017Jefferies Financial GroupReiterated RatingBuy$47.00Low
i
7/14/2017Bank of AmericaBoost Price TargetBuy$46.50 ➝ $47.50Low
i
7/13/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$42.00 ➝ $46.00Low
i
7/11/2017Sanford C. BernsteinReiterated RatingOutperformMedium
i
6/19/2017Credit Suisse GroupReiterated RatingNeutral$39.00 ➝ $40.50Low
i
6/19/2017Cantor FitzgeraldReiterated RatingOverweight$44.00 ➝ $45.00Low
i
6/6/2017Morgan StanleyInitiated CoverageOverweight ➝ Overweight$43.00Medium
i
5/22/2017JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$37.50Medium
i
4/29/2017Jefferies Financial GroupReiterated RatingBuy$41.50 ➝ $42.50Low
i
4/26/2017Evercore ISIBoost Price TargetOutperform$40.00 ➝ $41.50High
i
4/26/2017Stifel NicolausBoost Price TargetBuy$40.00 ➝ $42.50High
i
4/25/2017Cantor FitzgeraldReiterated RatingBuy$42.50 ➝ $44.00Low
i
4/19/2017Jefferies Financial GroupReiterated RatingBuy$39.50Medium
i
4/5/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$42.00Low
i
3/23/2017CitigroupDowngradeBuy ➝ Neutral$36.50High
i
3/11/2017Cantor FitzgeraldReiterated RatingOverweight$42.50N/A
i
2/9/2017SVB LeerinkReiterated RatingMarket Perform$31.00 ➝ $32.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
2/8/2017Piper Jaffray CompaniesBoost Price TargetOverweight$33.50 ➝ $38.00N/A
i
2/8/2017BarclaysBoost Price TargetOverweight$37.50 ➝ $39.50N/A
i
2/8/2017Jefferies Financial GroupBoost Price TargetBuy$33.50 ➝ $39.50N/A
i
2/7/2017Cantor FitzgeraldInitiated CoverageOverweightN/A
i
2/6/2017Cantor FitzgeraldInitiated CoverageOverweight$42.50N/A
i
1/31/2017Sanford C. BernsteinUpgradeMarket Perform ➝ OutperformN/A
i
1/9/2017BarclaysReiterated RatingBuy$37.50N/A
i
1/4/2017Piper Jaffray CompaniesInitiated CoverageOverweight$33.50N/A
i
12/21/2016JPMorgan Chase & Co.Initiated CoverageOverweight$37.50N/A
i
12/20/2016OppenheimerReiterated RatingOutperformN/A
i
12/16/2016Jefferies Financial GroupReiterated RatingBuy$34.00 ➝ $33.50N/A
i
12/13/2016The Goldman Sachs GroupUpgradeSell ➝ NeutralN/A
i
11/14/2016Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$38.50 ➝ $34.50N/A
i
11/11/2016UBS GroupReiterated RatingBuy$40.00 ➝ $36.50N/A
i
Rating by A.J. Rice at UBS Group AG
11/11/2016Credit Suisse GroupDowngradeOutperform ➝ Neutral$41.00 ➝ $30.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
10/16/2016Jefferies Financial GroupReiterated RatingBuy$41.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
10/5/2016Credit Suisse GroupLower Price TargetOutperform$39.00 ➝ $38.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
10/4/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Ana Gupte at SVB Leerink LLC
10/4/2016UBS GroupSet Price TargetBuy$40.00N/A
i
Rating by a.j. rice at UBS Group AG
9/29/2016Cantor FitzgeraldReiterated RatingBuyN/A
i
Rating by Joseph France at Cantor Fitzgerald
9/22/2016Evercore ISIInitiated CoverageBuy$39.50N/A
i
9/13/2016Credit Suisse GroupReiterated RatingBuy$39.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
9/7/2016WedbushReiterated RatingOutperform$42.50N/A
i
9/6/2016UBS GroupSet Price TargetBuy$40.00N/A
i
Rating by a.j. rice at UBS Group AG
9/6/2016SVB LeerinkDowngradeOutperform ➝ Market Perform$40.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
9/1/2016(FBRC)Reiterated RatingBuyN/A
i
Rating by Steven Halper at (FBRC)
9/1/2016Credit Suisse GroupReiterated RatingBuy$39.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
8/31/2016UBS GroupReiterated RatingBuyN/A
i
Rating by a.j. rice at UBS Group AG
7/28/2016UBS GroupReiterated RatingBuy$40.00N/A
i
7/27/2016Jefferies Financial GroupLower Price TargetBuy$44.50 ➝ $41.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
7/26/2016(FBRC)Reiterated RatingOutperform$45.00N/A
i
Rating by Steven Halper at (FBRC)
6/29/2016Morgan StanleyUpgradeEqual Weight ➝ Overweight$42.00 ➝ $43.00N/A
i
Rating by Andrew Schenker at Morgan Stanley
6/28/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Scott Fidel at Credit Suisse Group AG
6/28/2016Wolfe ResearchInitiated CoverageMarket Perform$40.00N/A
i
6/21/2016UBS GroupReiterated RatingBuy$40.00N/A
i
6/20/2016CowenReiterated RatingBuyN/A
i
Rating by Christine Arnold at Cowen Inc
6/20/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
Rating by Peter Costa at Wells Fargo & Company
6/20/2016SVB LeerinkReiterated RatingOutperform$39.00 ➝ $40.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
6/20/2016OppenheimerReiterated RatingOutperform$44.50N/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
6/20/2016(FBRC)Reiterated RatingBuyN/A
i
6/20/2016BarclaysUpgradeEqual Weight ➝ Overweight$38.00 ➝ $41.00N/A
i
6/16/2016Sanford C. BernsteinInitiated CoverageUnderperform ➝ Market Perform$38.00N/A
i
6/8/2016Jefferies Financial GroupReiterated RatingBuy$40.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
6/4/2016Cantor FitzgeraldReiterated RatingBuyN/A
i
Rating by Joseph France at Cantor Fitzgerald
6/1/2016BarclaysBoost Price TargetEqual Weight$35.00 ➝ $36.00N/A
i
5/26/2016UBS GroupReiterated RatingBuy$40.00N/A
i
5/26/2016Stifel NicolausUpgradeHold ➝ Buy$37.50N/A
i
5/24/2016OppenheimerReiterated RatingBuy$44.50N/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
5/12/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Ana Gupte at SVB Leerink LLC
4/29/2016UBS GroupDowngradeBuy ➝ NeutralN/A
i
4/29/2016WedbushReiterated RatingOutperform$40.00N/A
i
4/27/2016Cantor FitzgeraldReiterated RatingBuyN/A
i
Rating by Joseph France at Cantor Fitzgerald
4/27/2016Morgan StanleyReiterated RatingHoldN/A
i
Rating by Andrew Schenker at Morgan Stanley
4/25/2016CowenInitiated CoverageOutperform$35.00N/A
i
4/5/2016Jefferies Financial GroupReiterated RatingBuy$40.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
4/2/2016CitigroupReiterated RatingBuyN/A
i
Rating by Ralph Giacobbe at Citigroup Inc.
3/28/2016Credit Suisse GroupBoost Price Target$35.00 ➝ $36.00N/A
i
Rating by Chris Carter at Credit Suisse Group AG
3/24/2016Credit Suisse GroupBoost Price TargetNeutral ➝ Outperform$51.00 ➝ $59.00N/A
i
Rating by Chris Carter at Credit Suisse Group AG
3/24/2016OppenheimerReiterated RatingBuy$44.50N/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
2/11/2016OppenheimerReiterated RatingOutperform$44.50N/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
2/11/2016(FBRC)Reiterated RatingOutperform$45.00N/A
i
Rating by Steven Halper at (FBRC)
2/11/2016WedbushReiterated RatingOutperform$40.00N/A
i
2/10/2016BarclaysLower Price TargetEqual Weight$36.00 ➝ $32.00N/A
i
Rating by Joshua Raskin at Barclays PLC
2/9/2016Cantor FitzgeraldReiterated RatingBuy$45.00N/A
i
Rating by Joseph France at Cantor Fitzgerald
1/27/2016OppenheimerReiterated RatingOutperform$44.50N/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
1/26/2016(FBRC)Reiterated RatingOutperformN/A
i
Rating by Steven Halper at (FBRC)
(Data available from 1/16/2016 forward)
Centene logo
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; and vision and dental, and management services, as well as care management software that automate the clinical, administrative, and technical components of care management programs; staffing services; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. Centene Corporation has a collaboration with AT&T. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Read More

Today's Range

Now: $63.99
$63.51
$64.83

50 Day Range

MA: $62.50
$58.02
$69.75

52 Week Range

Now: $63.99
$43.96
$74.70

Volume

4,052,269 shs

Average Volume

4,347,978 shs

Market Capitalization

$37.10 billion

P/E Ratio

17.82

Dividend Yield

N/A

Beta

0.55

Frequently Asked Questions

What sell-side analysts currently cover shares of Centene?

The following equities research analysts have issued stock ratings on Centene in the last twelve months: Bank of America Co., Barclays PLC, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Sanford C. Bernstein, Stephens, SunTrust Banks, Inc., SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Wells Fargo & Company, and Zacks Investment Research.

What is the current price target for Centene?

16 Wall Street analysts have set twelve-month price targets for Centene in the last year. Their average twelve-month price target is $83.91, suggesting a possible upside of 31.1%. Sanford C. Bernstein has the highest price target set, predicting CNC will reach $103.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $67.50 for Centene in the next year.

What is the current consensus analyst rating for Centene?

Centene currently has 3 hold ratings, 13 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CNC will outperform the market and that investors should add to their positions of Centene.

What other companies compete with Centene?

Other companies that are similar to Centene include UnitedHealth Group, Anthem, Cigna, Humana, Molina Healthcare, Magellan Health and Triple-S Management.

How do I contact Centene's investor relations team?

Centene's physical mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company's listed phone number is 314-725-4477 and its investor relations email address is investors@centene.com. The official website for Centene is www.centene.com.